| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/02/2011 | US7989182 Nucleic acid encoding SCN1A variant |
| 08/02/2011 | US7988977 Modified live Aeromonas hydrophila vaccine for aquatic animals |
| 08/02/2011 | US7988959 Method of treatment using organotypically cultured skin tissue comprising niks cells that express exogenous HIF-1a |
| 08/02/2011 | US7988957 Histone deacetylase inhibitor; adeno-associated virus vector; gene therapy; packages |
| 08/02/2011 | CA2486678C Non-viral gene delivery system |
| 08/02/2011 | CA2484604C .delta. 4,5 glycuronidase and uses thereof |
| 08/02/2011 | CA2442682C Monocyte-specific particulate delivery vehicle |
| 08/02/2011 | CA2407309C Dna sequences encoding dystrophin minigenes and methods of use thereof |
| 08/02/2011 | CA2349038C Methods of alleviating cancer symptoms |
| 08/02/2011 | CA2332655C Scce modified transgenic mammals and their use as models of human diseases |
| 08/02/2011 | CA2330829C Methods for treating a neurological disease by determining bche genotype |
| 07/28/2011 | WO2011091390A2 Treatment of rnase h1 related diseases by inhibition of natural antisense transcript to rnase h1 |
| 07/28/2011 | WO2011091304A1 Delivery system for diagnostic and therapeutic agents |
| 07/28/2011 | WO2011091138A1 Combination therapy to treat autoimmune diseases |
| 07/28/2011 | WO2011090741A2 TREATMENT OF TUMOR PROTEIN 63 (p63) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO p63 |
| 07/28/2011 | WO2011090740A2 Treatment of nuclear respiratory factor 1 (nrf1) related diseases by inhibition of natural antisense transcript to nrf1 |
| 07/28/2011 | WO2011089595A2 Sustained-release nucleic acid matrix compositions |
| 07/28/2011 | WO2011089541A1 Methods for intracellular delivery of nucleic acids |
| 07/28/2011 | WO2011035244A3 Tctex-1 regulatory sequence region as stem cell marker |
| 07/28/2011 | WO2011017516A3 Treatment of insulin gene (ins) related diseases by inhibition of natural antisense transcript to an insulin gene (ins) |
| 07/28/2011 | US20110184153 Modified gherlin peptides |
| 07/28/2011 | US20110184050 Methods and means for treating dna repeat instability associated genetic disorders |
| 07/28/2011 | US20110184049 Liver-specific nucleic acid regulatory elements and methods and use thereof |
| 07/28/2011 | US20110184048 Uses and Compositions Comprising miRNAs |
| 07/28/2011 | US20110183907 Factor viii, von willebrand factor or complexes thereof with prolonged in vivo half-life |
| 07/28/2011 | US20110183894 Antiviral activity of the protein scytovirin and methods of use |
| 07/28/2011 | US20110182979 In-Vivo Non-Viral Gene Delivery of Human Vascular Endothelial Growth Factor Following Islet Transplantation |
| 07/28/2011 | US20110182945 Semi-allogenic anti-tumour vaccine with hla haplo-identical antigen-presenting cells |
| 07/28/2011 | US20110182933 Modified vaccinia ankara virus variant |
| 07/28/2011 | US20110182932 Modified vaccinia ankara virus variant |
| 07/28/2011 | US20110182927 Inhibitors of DNA Immunostimulatory Sequence Activity |
| 07/28/2011 | US20110182910 Method of treating t cell mediated disorders |
| 07/28/2011 | US20110182893 Prevention and treatment of amyloidogenic diseases |
| 07/28/2011 | US20110182864 Compositions containing inclusion complexes |
| 07/28/2011 | US20110182857 Delivery of Drugs to Mucosal Surfaces |
| 07/28/2011 | US20110182805 Nanoparticle fabrication methods, systems, and materials |
| 07/28/2011 | CA2786766A1 Methods for intracellular delivery of nucleic acids |
| 07/28/2011 | CA2786568A1 Treatment of rnase h1 related diseases by inhibition of natural antisense transcript to rnase h1 |
| 07/28/2011 | CA2785177A1 Treatment of tumor protein 63 (p63) related diseases by inhibition of natural antisense transcript to p63 |
| 07/28/2011 | CA2785173A1 Treatment of nuclear respiratory factor 1 (nrf1) related diseases by inhibition of natural antisense transcript to nrf1 |
| 07/28/2011 | CA2783001A1 Sustained-release nucleic acid matrix compositions |
| 07/28/2011 | CA2781733A1 Delivery system for diagnostic and therapeutic agents |
| 07/27/2011 | EP2348135A2 Identification of surface-associated antigenes used for the diagnosis and therapy of tumours |
| 07/27/2011 | EP2348134A1 RNA interference mediating small RNA molecules |
| 07/27/2011 | EP2348133A1 RNA interference mediating small RNA molecules |
| 07/27/2011 | EP2348119A2 Multicistronic lentiviral vector |
| 07/27/2011 | EP2348118A1 A polynucleotide comprising a ubiquitous chromatin opening element (ucoe) |
| 07/27/2011 | EP2348104A1 Multipotent adult stem cells and methods for isolation |
| 07/27/2011 | EP2348047A1 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
| 07/27/2011 | EP2348042A1 Modified amyloid beta peptide |
| 07/27/2011 | EP2347768A1 Novel use application of sugar chain-recognizing receptor |
| 07/27/2011 | EP2346996A1 Transfection with magnetic nanoparticles and ultrasound |
| 07/27/2011 | EP2346895A1 Methods and compositions for inhibiting propagation of viruses using recombinant tetherin constructs |
| 07/27/2011 | EP2346883A2 Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating rna interference |
| 07/27/2011 | EP2346531A2 Tumor vaccine |
| 07/27/2011 | EP1560931B1 Functional and hyperfunctional sirna |
| 07/27/2011 | EP1435993B1 Utilisation d'une proteine de la famille des crmps pour le traitement des maladies liees au systeme immunitaire |
| 07/27/2011 | EP1278823B1 Clearance of neoplastic cells from mixed cellular compositions using viruses |
| 07/27/2011 | EP1071805B1 Adenoviral vectors for treating disease |
| 07/27/2011 | CN1966684B Construction of HER2/neu mRNA in vitro transcription vector and use thereof |
| 07/27/2011 | CN1747744B Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene |
| 07/27/2011 | CN102137930A Double-stranded polynucleotide |
| 07/27/2011 | CN102137682A Anti-hepatitis c virus composition |
| 07/27/2011 | CN102133430A Inductive agent for regeneration of periodontium tissue of temperature sensitivity and preparation method thereof |
| 07/27/2011 | CN102133405A Preparation method and application of liposome-chitosan compound gene carrier |
| 07/27/2011 | CN102133404A Tumor targeted therapeutic drug carrier as well as preparation method and application thereof |
| 07/27/2011 | CN101497653B Small peptide for inhibiting solid tumor and leukaemia cancer cell growth and use thereof |
| 07/27/2011 | CN101492690B Plasmid vector of polygene combined gene therapy based on RNAi technique |
| 07/27/2011 | CN101363027B Method for preparing recombination plasmid carrying short hairpin RNA and use |
| 07/27/2011 | CN101357227B Senile dementia recombinant adenovirus gene vaccine and preparation method thereof |
| 07/27/2011 | CN101220375B Fowl pox virus double-gene expression carrier (PT7.5N) |
| 07/27/2011 | CN101168594B Polyglycol active derivative with oligopeptide as framework, preparation method thereof and conjugate of with pharmaceutical molecule |
| 07/26/2011 | US7985887 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/26/2011 | US7985854 siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1) |
| 07/26/2011 | US7985835 Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) |
| 07/26/2011 | US7985834 Compositions and methods for increasing bone mineralization |
| 07/26/2011 | US7985587 Methods of culturing dermal papilla cells |
| 07/26/2011 | US7985563 HIFαprolyl hydroxylation assay |
| 07/26/2011 | US7985407 Method of treating solid tumor |
| 07/26/2011 | CA2441225C A novel trp2 isoform containing hla-a2 restricted cytotoxic t lymphocyte epitopes |
| 07/26/2011 | CA2411249C Gasc1 gene |
| 07/26/2011 | CA2405169C Devices and formulations |
| 07/26/2011 | CA2376346C Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 07/26/2011 | CA2333162C Process for producing composite preparation containing nucleic acid |
| 07/26/2011 | CA2221409C Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same |
| 07/26/2011 | CA2215350C Transforming growth factor alpha hii |
| 07/21/2011 | WO2011087804A2 Peptide-polynucleotide compositions, and methods for transfecting a cell with dna and treatment of neurodegenerative disease |
| 07/21/2011 | WO2011087548A2 Therapeutic compositions and methods for targeted delivery of active agents |
| 07/21/2011 | WO2011087066A1 Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or elevated ocular vascular permeability |
| 07/21/2011 | WO2011087009A1 Regulatory gene controlling saccharometabolism, lipid metabolism, obesity and life, protein, and screening method |
| 07/21/2011 | WO2011008947A3 Treatment and diagnosis of immune disorders |
| 07/21/2011 | WO2011006133A3 Bioengineered silk protein-based nucleic acid delivery systems |
| 07/21/2011 | WO2010151674A3 Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene |
| 07/21/2011 | WO2010151671A3 Treatment of tumor necrosis factor receptor 2 (tnfr2) related diseases by inhibition of natural antisense transcript to tnfr2 |
| 07/21/2011 | US20110179501 Methods for Reverting Methylation by Targeting DNMT3A and DNMT3B |
| 07/21/2011 | US20110178161 Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin |
| 07/21/2011 | US20110178030 Methods of treating inflammatory intestinal disease and managing symptoms thereof |
| 07/21/2011 | US20110177997 Cross-Beta Silk Genes |
| 07/21/2011 | US20110177595 Multipotent Adult Stem Cells, Sources Thereof, Methods of Obtaining and Maintaining Same, Methods of Differentiation Thereof, Methods of Use Thereof and Cells Derived Thereof |
| 07/21/2011 | US20110177556 Nucleic Acids Encoding Chimeric CD154 Polypeptides |